TC

Investment firm

Tekla Capital Management

Private equity, Venture capital

LinkedIn pageCrunchbase profileBoston·Massachusetts·United States9known portfolio companies1person tracked19co-investors

Tekla Capital Management is a private equity firm and venture capital firm. The one team member on file is in Boston, Massachusetts, United States. Among the 9 companies in the known portfolio are Abcuro, HotSpot Therapeutics, Amolyt Pharma, Oculis, Invetx and MoonLake Immunotherapeutics.

Is Tekla Capital Management a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

inf***@***.comAvailable after registration.
Get contact

Who to pitch at Tekla Capital Management

Tekla Capital Management portfolio companies (9)

  • Abcuro
  • HotSpot Therapeutics
  • Amolyt Pharma
  • Oculis
  • Invetx
  • MoonLake Immunotherapeutics
  • Quell Therapeutics
  • Arkuda Therapeutics
  • Endeavor BioMedicines

Co-investors

Funds that share portfolio companies with Tekla Capital Management.

Similar funds

Showing 20 of 100

About Tekla Capital Management

The firm's listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, Genomics and Pharma; known deals cluster at Growth, Late-Stage and Series B.

The contact to approach at Tekla Capital Management is Daniel Omstead (CEO).

Across the known portfolio, 19 co-investors appear alongside Tekla Capital Management, including Monashee Investment Management, Ridgeback Capital and Merck Kgaa, Darmstadt, Germany.

Frequently asked questions

What is Tekla Capital Management?

Tekla Capital Management is a private equity firm and venture capital firm whose one person on file is in Boston, Massachusetts, United States, with a known portfolio of 9 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Tekla Capital Management invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Genomics and Pharma. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Tekla Capital Management invest at?

The known deals of Tekla Capital Management include Growth, Late-Stage and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Tekla Capital Management?

One person at Tekla Capital Management is on file, listed as a contact for the firm, with their own profile page.

How do I contact Tekla Capital Management?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The one person attached to the firm has their own page, which shows whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal